2020
DOI: 10.21037/jtd-2019-cptn-03
|View full text |Cite
|
Sign up to set email alerts
|

Putting artificial intelligence (AI) on the spot: machine learning evaluation of pulmonary nodules

Abstract: Lung cancer remains the leading cause of cancer related death world-wide despite advances in treatment. This largely relates to the fact that many of these patients already have advanced diseases at the time of initial diagnosis. As most lung cancers present as nodules initially, an accurate classification of pulmonary nodules as early lung cancers is critical to reducing lung cancer morbidity and mortality. There have been significant recent advances in artificial intelligence (AI) for lung nodule evaluation.… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
24
0

Year Published

2021
2021
2025
2025

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(24 citation statements)
references
References 87 publications
0
24
0
Order By: Relevance
“…Well known candidates are software packages that search for specific lesions in specific types of images, such as acquired in the frame of organized screening [38,39] but many questions must be answered before they gain wide spread use in organized breast cancer screening [40] and in other domains of medicine [41]. Other AI tools also have the potential to achieve global acceptance, in many domains of medicine [42][43][44]. Typical results are lower noise (reconstructed) images, segmentation of specific anatomical parts of interest, quantitative data of all (cancerous) lesions rather than subjective readings of only a selection, quantitative lesion follow up, new data or insights in new diseases, the comparison of quantitative image data to that of other patients or to asymptomatic groups to better situate the patient's disease or prognosis, and improved outcome in general.…”
Section: Discussionmentioning
confidence: 99%
“…Well known candidates are software packages that search for specific lesions in specific types of images, such as acquired in the frame of organized screening [38,39] but many questions must be answered before they gain wide spread use in organized breast cancer screening [40] and in other domains of medicine [41]. Other AI tools also have the potential to achieve global acceptance, in many domains of medicine [42][43][44]. Typical results are lower noise (reconstructed) images, segmentation of specific anatomical parts of interest, quantitative data of all (cancerous) lesions rather than subjective readings of only a selection, quantitative lesion follow up, new data or insights in new diseases, the comparison of quantitative image data to that of other patients or to asymptomatic groups to better situate the patient's disease or prognosis, and improved outcome in general.…”
Section: Discussionmentioning
confidence: 99%
“…One also has to keep in mind that most algorithms are tested on datasets, which are very similar to the training datasets, a fact that may cause an overestimation of their performance; this phenomenon has been described in the literature as "overfitting" (33). Despite the promising results of AI-supported diagnostic modules, widespread implementation is still delayed; mostly owed to inadequate performance, lack of workflow integration and assessment tools (32,33).…”
Section: Discussionmentioning
confidence: 99%
“…However, detection of lung nodules is not as simple as it looks, as pulmonary nodules usually appear as a white spherical structure that could mimic a nearby small blood vessel or a collapsed bronchiole. In addition, the inter-reader variations in detection and the characterization of pulmonary nodules are merely subjective issues [ 10 , 78 , 79 ]. This opens the way for artificial intelligence and deep learning to overcome human errors and provide more effective procedures.…”
Section: Pulmonary Nodule Detection and Segmentationmentioning
confidence: 99%